期刊文献+

中老年人骨转换标志物联合测定的指标分析 被引量:4

The measuring and index analysis of bone turnover markers in the middle-aged and elderly person
下载PDF
导出
摘要 目的:通过对存在骨质疏松等骨病患者血清骨标志物的测定,结合X线影像分析,探讨骨标志物在骨质疏松性疾病诊断中的表达及意义。方法收集2011年10月至2012年9月期间到我院就诊的骨病患者400例,骨质疏松组200例,骨折事件组200例,分别于早上7:00~9:00进行静脉采血和X线摄影,血液样本同时测定骨转换标志物组合血清β-胶原降解产物(β-crosslaps)、N 端骨钙素(N-MID)、甲状旁腺素(PTH),收集骨标志物结果和X线影像结果,对照X线影像结果进行分析。结果结合X线摄影结果判断,2组 X线影片结果均显示存在不同程度的骨质退行性改变或骨质疏松症,骨折患者合并有骨质疏松性骨折表现。400例患者骨标志物组合显示,单独检测β-crosslaps阳性率占72.7%,N-MID阳性率占13.0%,PTH阳性率占7.5%。联合检测阳性率占75.5%。结论作为骨标志物,β-胶原交联C末端肽(β-CTX)可作为骨质疏松症的独立风险预测指标,联合测定或结合X线影像结果分析有利于提高骨质疏松症的风险评估。 Objective To investigate the sensitivity expression of bone markers in the diagnosis of osteoporosis and osteoporotic fractures by measuring bone markers between the osteoporosis and bone disease patients and combined with the X-ray analysis. Methods Four hundred patients from October 2011 to September 2012 in our hospital were collected, 200 cases were in the osteoporosis group while 200 cases were in the bone fractures group. At 7-9 o′clock in the morning, all cases underwent both venous blood collection and X-ray photography. At the same time, all blood samples also had been measured bone turnover markers including serum β-collagen degradation products(β-crosslaps), N-terminal osteocalcin (N-MID) and parathyroid hormone (PTH). Analyse the sensitivity and specificity of the bone turnover maker results with X-ray images results. Results With X-ray photography judgement, two X-ray image results showed that all patients had different degrees of bone degenerative changes , especially the patients in fracture group had osteoporotic fractures. The bone turnover markers results of 400 patients showed the positive rate was respectively 72.7%, 13.0% and 7.5% by β-CTX、N-MID and PTH, and the positive rate was 75.5% by combined detection of both bone turnover maker and X-ray. Conclusion β-crosslaps could be used as a more independent predictor of osteoporosis , and combined with X-ray results, it could improve the osteoporosis diagnosis.
出处 《实用医技杂志》 2014年第6期598-601,共4页 Journal of Practical Medical Techniques
关键词 骨重建 生物学标记 骨质疏松症 骨折 放射摄影术 Bone remodeling biological maker Osteoporosis Fracture Radiography
  • 相关文献

参考文献9

  • 1原发性骨质疏松症诊治指南(2011年)[J].中华骨质疏松和骨矿盐疾病杂志,2011,4(1):2-17. 被引量:1831
  • 2Garnero P, Grimaux M, Seguin P, et al. Charav, terization of immunoreactive forms of human osteocalcin generated in vivo and in vitro[J]. J Bone Miner Res, 1994, 9(2): 255-264.
  • 3Chenj T, Hosoda K, Hasumi K, et al. Sermn N-terninal osteoc- alcin is a good indicator ibr estimating responders to hormojae replacement therapy in postmenopausal women[J]. J Bone Miner Res, 1996, 11(11): 1784-1792.
  • 4Bonde M, Qvist P, Fledeliue C, et al. hnmunoassay tor quantifying type I collagen degradation products in urine evaluated[J]. Clin Chem, 1994, 40( 11 ) : 2022-2025.
  • 5Fledelius C, Johnsen A, Cloos PA, et al. Characterization of urinary degradation products derived from type 1 collagen: identification of a beta-ysomerized Asp ,Gly sequence within the C-terminal telpeptide(alpha 1) region[J]. J Boil Chen, 1997, 27 ( 15 ) : 9755-9763.
  • 6Bonde M, Qvist P, Fledelius C, et al. Applications of an enzyme immunoassay for a new marker of bone resorption (Crosslaps): follow-up on hormone replacement therapy and osteoporosis risk assessment[J]. J Clin Endocrinol Metab, 1995, 80: 864-868.
  • 7Ravn P, Clemmesne B, Riis B J, et al. The effect on bone mass and bone markers of different doses of ibandronate: a newbisphos-phonate for prevention and treatment of postmenopausal osteoporosis. A 1-year, randomized, double-blind, placebo-con- trolled dose-finding study[J]. Bone, 1996, 19(5): 527-533.
  • 8Garnero P, Sornay-Rendu E, Duboeuf F, et al. Markers of bone turnover predict postmenopausal forearm bone loss over 4 years: the OFELY study[J]. J Bone Miner Res, 1999, 14: 1614-1621.
  • 9Colwell A, Eastell R. The renal clearance of free and conjugated pyridinium cross-links of collagen[J]. J Bone Miner Res, 1996, 11: 1976-1980.

共引文献1830

同被引文献25

  • 1何伟东,柯楚群,许鸿灏,黄新宇,林毅忠,李松军.老年桡骨远端骨折患者骨组织形态计量分析[J].第四军医大学学报,2005,26(13):1200-1202. 被引量:5
  • 2张晓娜,李忠信.监测骨折愈合的生物化学骨标志物[J].中国全科医学,2006,9(1):65-67. 被引量:6
  • 3伍西羽,伍贤平,廖二元.骨转换指标和骨密度监测治疗骨质疏松及其与骨折的关系[J].中国骨质疏松杂志,2007,13(11):797-802. 被引量:15
  • 4Garnero P,Delmas PD.Biochemical markers of bone turn over[J].Endocrinol Metab Clin North Am,1998,27:303-322.
  • 5Srivastava AK,Mac Farlane G,Srivastava VP,et al.A new monoclonalantibody ELISA for detection and characterization of C-telopeptide fragments of typeⅠcollagen in urine[J].Calcif Tissue Int,2001,69(6):327-336.
  • 6Cummings SR,Karpf DB,Harris F,et al.Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs[J].Am J Med,2002,112(4):281-289.
  • 7Garnero P,Sornay Rendu E,Duboeuf F,et al.Markers of bone turnover predict postmenopausal forearm bone loss over 4 years:the OFELY study[J].J Bone Miner Res,1999,14(9):1614-1621.
  • 8Filip RS,Zagórski J.Age and BMD related differences in biochemical markers of bone metabolism in rural and urban women from Lublin Region,Poland[J].Ann Agric Environ Med,2004,11:255-259.
  • 9贺石林,陈修.医学科研方法孚论(第1版)[M].北京:人民卫生出版社.1998.368-390.
  • 10陈广原,彭妙官,许佩君,石永英.体检人群骨标志物与年龄变化及性别的关系[J].广东医学,2011,32(9):1132-1133. 被引量:5

引证文献4

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部